Pharmacologic trends of heart failure /

Saved in:
Bibliographic Details
Imprint:Switzerland : Springer, 2016.
Description:1 online resource (vii, 173 pages) : illustrations (some color)
Language:English
Series:Current cardiovascular therapy
Current cardiovascular therapy.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11263880
Hidden Bibliographic Details
Other authors / contributors:Ventura, Hector O., editor.
ISBN:9783319305936
331930593X
3319305913
9783319305912
9783319305912
Notes:Includes index.
Online resource; title from PDF title page (SpringerLink, viewed June 29, 2016).
Summary:This volume reviews potential future therapies for heart failure, with a particular focus on ambulatory acute decompensated heart failure and the transitions from therapies in the acute setting to chronic management. Although in the developed world the incidence of and mortality from coronary heart disease and stroke have been declining over the last 15 years, heart failure is increasing in incidence, prevalence and overall mortality, despite advances in the diagnosis and management of the condition. Pharmacologic Trends of Heart Failure builds on the current understanding of pathophysiological mechanisms and insights gained from previous studies of therapeutic interventions. It is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis.
Other form:Printed edition: 9783319305912
Standard no.:10.1007/978-3-319-30593-6

MARC

LEADER 00000cam a2200000Ii 4500
001 11263880
005 20210625184917.2
006 m o d
007 cr cnu|||unuuu
008 160621s2016 sz a o 001 0 eng d
015 |a GBB954220  |2 bnb 
016 7 |a 019305028  |2 Uk 
020 |a 9783319305936  |q (electronic bk.) 
020 |a 331930593X  |q (electronic bk.) 
020 |a 3319305913  |q (print) 
020 |a 9783319305912  |q (print) 
020 |z 9783319305912  |q (print) 
024 7 |a 10.1007/978-3-319-30593-6  |2 doi 
035 |a (OCoLC)951975132 
035 9 |a (OCLCCM-CC)951975132 
037 |a com.springer.onix.9783319305936  |b Springer Nature 
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d YDXCP  |d IDEBK  |d GW5XE  |d AZU  |d OCLCF  |d N$T  |d COO  |d CASUM  |d UAB  |d OCLCQ  |d OCLCO  |d IAD  |d JBG  |d ICW  |d OCLCO  |d ILO  |d ICN  |d OCLCQ  |d ESU  |d IOG  |d U3W  |d REB  |d WYU  |d UKMGB  |d OCLCQ  |d OCLCO  |d UKAHL  |d OCLCA  |d AJS 
049 |a MAIN 
050 4 |a RC685.C53 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
245 0 0 |a Pharmacologic trends of heart failure /  |c Hector O. Ventura, editor. 
264 1 |a Switzerland :  |b Springer,  |c 2016. 
300 |a 1 online resource (vii, 173 pages) :  |b illustrations (some color) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Current cardiovascular therapy 
500 |a Includes index. 
588 0 |a Online resource; title from PDF title page (SpringerLink, viewed June 29, 2016). 
505 0 |a The Established Therapies: HF-PEF and HF-REF -- Novel Therapies for the Prevention and Management of Acute Decompensated Heart Failure -- A Comprehensive Transition of Care Plan For a Patient Admitted with Acute Decompensated Heart Failure -- Volume Assessment and Management: Medical and Device Therapies. 
520 |a This volume reviews potential future therapies for heart failure, with a particular focus on ambulatory acute decompensated heart failure and the transitions from therapies in the acute setting to chronic management. Although in the developed world the incidence of and mortality from coronary heart disease and stroke have been declining over the last 15 years, heart failure is increasing in incidence, prevalence and overall mortality, despite advances in the diagnosis and management of the condition. Pharmacologic Trends of Heart Failure builds on the current understanding of pathophysiological mechanisms and insights gained from previous studies of therapeutic interventions. It is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. 
650 0 |a Heart failure  |x Chemotherapy. 
650 1 2 |a Heart Failure  |x drug therapy. 
650 2 2 |a Drug Design. 
650 2 2 |a Technology, Pharmaceutical  |x trends. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Heart failure  |x Chemotherapy.  |2 fast  |0 (OCoLC)fst00953725 
655 0 |a Electronic books. 
655 4 |a Electronic books. 
700 1 |a Ventura, Hector O.,  |e editor.  |0 http://id.loc.gov/authorities/names/n2009180229 
776 0 8 |i Printed edition:  |z 9783319305912 
830 0 |a Current cardiovascular therapy.  |0 http://id.loc.gov/authorities/names/n2013182759 
903 |a HeVa 
929 |a oclccm 
999 f f |i 5c09fbf5-94c3-584d-958f-ccc392e58102  |s 2950317f-04d1-53e0-afee-298fa92b3ed7 
928 |t Library of Congress classification  |a RC685.C53  |l Online  |c UC-FullText  |u https://link.springer.com/10.1007/978-3-319-30593-6  |z Springer Nature  |g ebooks  |i 12538075